• Partial BACE1 Inhibition Reduces Amyloid Beta Without Synapt

  2026-06-19

  Satir et al. (2020) demonstrate that moderate inhibition of BACE1, the β-secretase involved in amyloid precursor protein processing, can reduce amyloid beta production by up to 50% without impairing synaptic transmission in neuronal cultures. These findings provide a critical framework for optimizing BACE inhibitor dosing in Alzheimer's disease research and support precision approaches for minimizing off-target neurological effects.

• Cyclic di-GMP: Advanced Workflows for Biofilm and Immunity R

  2026-06-19

  Cyclic di-GMP stands at the crossroads of bacterial genome stability and innate immune modulation, uniquely enabling dual-domain experimental designs. This article details robust protocols, troubleshooting strategies, and innovative applications for maximizing reproducibility and insight in infection biology and cancer immunotherapy studies.

• SkQ1 and Mitochondrial Apoptosis in Muscle Atrophy During Ov

  2026-06-18

  This study evaluates whether mitochondrial-targeted antioxidant SkQ1 can prevent skeletal muscle atrophy by inhibiting apoptotic and necroptotic signaling in a mouse model of ovarian cancer. The findings reveal that while SkQ1 suppresses mitochondrial apoptosis signaling, it does not prevent muscle atrophy, challenging the assumed causality between mitochondrial cell death pathways and cancer cachexia.

• High-Sensitivity Yeast Platform Accelerates mTOR Inhibitor D

  2026-06-18

  This study introduces a drug-sensitized yeast system that enables rapid, cost-effective, and highly sensitive detection of mTOR (TOR) inhibitors. The approach represents a major methodological advance for identifying compounds with geroprotective or anti-cancer potential, and provides robust negative controls for compounds like Nebivolol hydrochloride that do not affect the TOR pathway.

• Mechanistic Insights into Gyrase Inhibition: Lessons from Ge

  2026-06-17

  This article analyzes the mechanistic and structural basis of gepotidacin’s action against Staphylococcus aureus gyrase, revealing a novel inhibition mode distinct from classic fluoroquinolones. The findings provide new perspectives on antibiotic design, resistance, and research applications relevant to DNA gyrase-targeting compounds.

• Strainer Platform Advances Immunolabeling of PEDV-Infected O

  2026-06-17

  This study introduces a strainer-based method for the efficient collection and immunolabeling of porcine intestinal organoids infected by porcine epidemic diarrhea virus (PEDV). The innovation streamlines workflows for virus-host interaction studies, offering a reproducible, species-adaptable platform with implications for organoid-based disease models.

• Phosbind Biotin LC: Sequence-Independent Phosphoprotein Dete

  2026-06-16

  Phosbind Biotin LC enables sequence-independent detection of phosphorylated proteins on PVDF membranes, solving the challenge of Western Blot workflows where phospho-specific antibodies are unavailable or insufficient. It should not be used with aqueous-only protocols or for long-term storage of working solutions due to solubility and stability limitations.

• SepM Mutations Enhance S. mutans Inhibition of S. gordonii:

  2026-06-16

  Liu et al. (2024) identify specific sepM gene mutations in Streptococcus mutans that increase its ability to inhibit Streptococcus gordonii, a key interaction in oral biofilm dynamics and caries development. Their mechanistic and functional analyses highlight the pH-dependent effects of SepM variants on CSP-21 cleavage, offering new perspectives for microbial community modulation in dental health.

• Exemestane in Precision Endocrine Research: Mechanisms & Imp

  2026-06-15

  Explore the advanced mechanism of Exemestane, a steroidal aromatase inhibitor, and its role in precision endocrine research. This in-depth analysis reveals how Exemestane uniquely enables translational insights into estrogen biosynthesis inhibition.

• Streptavidin-FITC: Precision Tools for Quantitative Biotin D

  2026-06-15

  Explore how Streptavidin-FITC enables precision, quantitative detection of biotinylated molecules across immunohistochemistry and flow cytometry. This deep dive unpacks innovative assay strategies and recent mechanistic insights for advanced researchers.

• Rotigotine in Neuropsychiatric Models: Beyond Dopaminergic A

  2026-06-14

  Explore how Rotigotine, a dopamine D2/D3 receptor agonist, advances both motor and mood disorder research. This article uniquely examines Rotigotine’s neuroprotective and antidepressant actions, integrating protocol guidance and critical literature insights.

• PD98059 in Mechanistic Apoptosis Control and Hepatoprotectio

  2026-06-13

  Explore how PD98059, a selective MEK inhibitor, enables precise control over apoptosis and cell cycle arrest. This article uniquely dissects its mechanistic impact in both cancer and hepatic oxidative stress models, providing new insights for advanced research.

• Balsalazide Prodrug Advances Ulcerative Colitis Remission In

  2026-06-12

  Wiggins and Rajapakse's study demonstrates that balsalazide, a novel 5-aminosalicylate (5-ASA) prodrug, offers enhanced efficacy and rapidity of remission induction in mild-to-moderate ulcerative colitis compared to existing therapies. Their systematic review highlights balsalazide’s favorable safety profile and mechanistic advantages in sustained colonic drug delivery.

• Erlotinib (NSC 718781) in EGFR Signaling: Protocols & Innova

  2026-06-12

  Erlotinib (NSC 718781) delivers precise, reversible EGFR kinase inhibition, powering cell-based and in vivo models that dissect oncogenic signaling and resistance. This guide translates the latest SCUBE3-targeting findings into actionable workflows, troubleshooting, and next-gen assay design—enabling cancer researchers to outpace tumor adaptation.

• Estradiol-ERα Modulates CD4+ T Cells via ER Stress After Hem

  2026-06-11

  This study reveals that 17β-estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by inhibiting endoplasmic reticulum stress through ERα and GPR30, but not ERβ. These findings clarify the mechanistic basis for estrogen receptor-mediated immune modulation following trauma and inform future research in endocrine therapy resistance and immune homeostasis.

14368 records 1/958 page Next 12345 下5页 Last page